EU-US investor dispute rules could prevent reversal of decision to outsource NHS services, critics warnBMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h373 (Published 20 January 2015) Cite this as: BMJ 2015;350:h373
- Rory Watson
Plans to give US companies the legal right to challenge public policy decisions that could affect their investments in Europe have been strongly criticised in a wide ranging consultation organised by the European Commission.
Health organisations in the United Kingdom in particular fear that the proposed “investor to state dispute settlement” (ISDS) system could be used by US corporations to contest any future UK government legislation to repeal the 2012 Health and Social Care Act or reverse the outsourcing of NHS resources to the private sector.
The consultation on the current Transatlantic Trade and Investment Partnership (TTIP) negotiations, held between 27 March …
Log in using your username and password
Log in through your institution
Sign up for a free trial